Kaden T, Alonso-Román R, Stallhofer J, Gresnigt MS, Hube B, Mosig AS (2025) Leveraging organ-on-chip models to investigate host-microbiota dynamics and targeted therapies for inflammatory bowel disease. Adv Healthc Mater 14(10), e2402756. (Review)

Lange T, Sprague JL, Vij R, Alonso-Roman R, Jablonowski N, Radosa S, Krüger T, Kniemeyer O, Hillmann F, Brakhage AA, Allert S, Brunke S, Hube B (2025) "Pour some sugar on me"-Environmental Candida albicans isolates and the evolution of increased pathogenicity and antifungal resistance through sugar adaptation. PLoS Pathog 21(10), e1013542.

Alonso-Roman R, Mosig AS, Figge MT, Papenfort K, Eggeling C, Schacher FH, Hube B^#, Gresnigt MS (2024) Organ-on-chip models for infectious disease research. Nat Microbiol 9(4), 891-904. (Review)

Kaden T^*, Alonso-Roman R^*, Akbarimoghaddam P^*, Mosig AS, Graf K, Raasch M, Hoffmann B, Figge MT^#, Hube B^#, Gresnigt MS^# (2024) Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity. Biomaterials 307, 122525.

Alonso-Roman R, Last A, Mirhakkak MH, Sprague JL, Möller L, Großmann P, Graf K, Gratz R, Mogavero S, Vylkova S, Panagiotou G, Schäuble S, Hube B^#, Gresnigt MS (2022) Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. Nat Commun 13(1), 3192.

García-Díaz M, Cendra MDM, Alonso-Roman R, Urdániz M, Torrents E, Martínez E (2022) Mimicking the intestinal host-pathogen interactions in a 3D in vitro model: The role of the Mucus layer. Pharmaceutics 14(8), 1552.